Low-dose pioglitazone safely provides clinical antiatherosclerotic effects for patients with coronary artery disease and metabolic syndrome

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2005)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要